Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets close in 4 hours 6 minutes
ALL ORDS
8,035.30
+41.10
(+0.51%)
ASX 200
7,761.30
+39.70
(+0.51%)
AUD/USD
0.6609
-0.0012
(-0.18%)
OIL
79.77
+0.51
(+0.64%)
GOLD
2,358.40
+18.10
(+0.77%)
Bitcoin AUD
95,065.90
+1,972.45
(+2.12%)
ArriVent BioPharma, Inc. (AVBP)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
17.99
+0.63
(+3.63%)
At close: 04:00PM EDT
17.99
0.00
(0.00%)
After hours:
04:01PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
Total revenue
0
0
0
Operating expenses
Research development
64,884
64,884
30,433
Selling general and administrative
9,706
9,706
6,473
Total operating expenses
74,590
74,590
36,906
Operating income or loss
-74,590
-74,590
-36,906
Income before tax
-69,333
-69,333
-36,906
Income from continuing operations
-69,333
-69,333
-36,906
Net income
-69,333
-69,333
-36,906
Net income available to common shareholders
-69,333
-69,333
-36,906
Basic EPS
-1.83
-
-1.15
Diluted EPS
-1.83
-
-1.15
Basic average shares
31,957
-
31,957
Diluted average shares
31,957
-
31,957
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.